Kazia Therapeutics (KZIA) Non-cash Items (2016)

Kazia Therapeutics (KZIA) posted Non-cash Items of -$2.4 million for Q4 2016.

Kazia Therapeutics (KZIA) Non-cash Items (2016) Analysis & Trends

Kazia Therapeutics' Non-cash Items history runs 1 years deep, the most recent figure standing at -$2.4 million for Q4 2016.

Quarterly Non-cash Items changed N/A year-over-year to -$2.4 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $21.4 million (changed N/A YoY) and the FY2017 annual result came in at -$5.6 million, up 31.26% from the prior year.
Non-cash Items was -$2.4 million for Q4 2016 at Kazia Therapeutics.
Across five years, Non-cash Items topped out at -$2.4 million in Q4 2016 and bottomed at -$2.4 million in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Kazia Therapeutics	4.11 Mn	4.11 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2016	-2.42 Mn
Dec 31, 2016	-2.42 Mn